Role of chemotherapy before allogeneic stem cell transplantation (allo-SCT) from an HLA-identical sibling donor for myelodysplastic syndrome (MDS).

被引：0
|
作者：
Nakai, K
Kanda, Y
Fukuhara, S
Sakamaki, H
Okamoto, S
Kodera, Y
Tanosaki, R
Takahashi, S
Matsushima, T
Atsuta, Y
Hamajima, N
Kasai, M
Kato, S
机构：
[1] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan
[2] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat Med, Tokyo 113, Japan
[3] Tokyo Metropolitan Komagome Hosp, Div Hematol, Tokyo, Japan
[4] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan
[5] Nagoya First Hosp, Japanese Red Cross, Dept Internal Med, Nagoya, Aichi, Japan
[6] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo 104, Japan
[7] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan
[8] Gunma Univ, Grad Sch med, Dept Med & Clin Sci, Gunma, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Prevent Med Biostat & Med Decis Making, Nagoya, Aichi, Japan
[10] Sapporo Hokuyu Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan
[11] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5126
引用
收藏
页码：365B / 365B
页数：1
相关论文
共 50 条
  • [41] Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS
    J De La Serna
    J Sanz
    A Bermúdez
    M Cabrero
    D Serrano
    C Vallejo
    V Gómez
    J M Moraleda
    S G Perez
    M D Caballero
    E Conde
    J J Lahuerta
    G Sanz
    Bone Marrow Transplantation, 2016, 51 : 961 - 966
  • [42] Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS
    De La Serna, J.
    Sanz, J.
    Bermudez, A.
    Cabrero, M.
    Serrano, D.
    Vallejo, C.
    Gomez, V.
    Moraleda, J. M.
    Perez, S. G.
    Caballero, M. D.
    Conde, E.
    Lahuerta, J. J.
    Sanz, G.
    BONE MARROW TRANSPLANTATION, 2016, 51 (07) : 961 - 966
  • [43] Successful allogeneic peripheral blood stem cell transplantation from an HLA-identical sibling in a patient with mitochondrial neurogastrointestinal encephalomyelopathy
    Hill, K. S.
    Richardson, D.
    Hammans, S.
    Stroud, M.
    Fine, D.
    Walker, V.
    Newman, J.
    McKeag, N.
    Hurlock, C.
    Orchard, K.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S184 - S185
  • [44] Younger HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation (allo-HCT) for Myelodysplastic Syndromes (MDS) Is Associated with Superior Disease-Free Survival Compared to Older HLA-Identical Sibling Donors: CIBMTR Analysis
    Murthy, Guru Subramanian Guru
    Kim, Soyoung
    Hu, Zhen-Huan
    Estrada-Merly, Noel
    Nakamura, Ryotaro
    Oran, Betul
    Scott, Bart L.
    Sobecks, Ronald
    Saber, Wael
    BLOOD, 2020, 136
  • [45] Allogeneic stem cell transplantation from HLA-identical sibling donor in high risk ALL patients is less effective than transplantation from unrelated donors.
    Arnold, R
    Bunjes, D
    Ehninger, G
    Finke, J
    Goekbuget, N
    Hertenstein, B
    Kienast, J
    Kolb, HJ
    Kolbe, K
    Massenkeil, G
    Niederwieser, D
    Schaefer, UW
    Schwerdtfeger, R
    Zander, AR
    Hoelzer, D
    BLOOD, 2002, 100 (11) : 77A - 77A
  • [46] Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings
    Kroeger, N.
    Zabelina, T.
    de Wreede, L.
    Berger, J.
    Alchalby, H.
    van Biezen, A.
    Milpied, N.
    Volin, L.
    Mohty, M.
    Leblond, V.
    Blaise, D.
    Finke, J.
    Schaap, N.
    Robin, M.
    de Witte, T.
    LEUKEMIA, 2013, 27 (03) : 604 - 609
  • [47] Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings
    N Kröger
    T Zabelina
    L de Wreede
    J Berger
    H Alchalby
    A van Biezen
    N Milpied
    L Volin
    M Mohty
    V Leblond
    D Blaise
    J Finke
    N Schaap
    M Robin
    T de Witte
    Leukemia, 2013, 27 : 604 - 609
  • [48] Outcomes of 138 myelodysplastic syndrome patients with HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation
    王茜茜
    China Medical Abstracts(Internal Medicine), 2020, 37 (02) : 115 - 115
  • [49] Successful combined haemopoietic stem cell and kidney transplantation from HLA-identical sibling donor in patient with multiple myelomas
    Lengyel, L.
    Remenyi, P.
    Barta, A.
    Batai, A.
    Csukly, Z.
    Torbagyi, E.
    Mikala, G.
    Farkas, Z.
    Fabry, L.
    Kozma, A.
    Reti, M.
    Rasonyi, R.
    Csomor, J.
    Wagner, L.
    Langer, R.
    Masszi, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S211 - S211
  • [50] Systemic toxoplasmosis post allogeneic stem cell transplantation (Allo-SCT): Lessons learned from HIV?
    von Lilienfeld-Toal, Marie
    Gilleece, Maria
    Cook, Gordon
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (07) : 871 - 872
12345